Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.
作者信息
Ward E A, Ward G M, Turner R C
出版信息
Br Med J (Clin Res Ed). 1981 Jul 25;283(6286):278. doi: 10.1136/bmj.283.6286.278.
Abstract
摘要
相似文献
1
Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.磺脲类药物对接受胰岛素治疗的糖尿病患者胰岛素分泌及血糖控制的影响。
Br Med J (Clin Res Ed). 1981 Jul 25;283(6286):278. doi: 10.1136/bmj.283.6286.278.
2
Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.
Diabetologia. 1979 Nov;17(5):287-90. doi: 10.1007/BF01235884.
3
Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.格列戊脲（司达立）与格列本脲治疗糖尿病的临床比较
Curr Ther Res Clin Exp. 1977 Jan;21(1):50-7.
4
Mild familial diabetes with dominant inheritance.轻度显性遗传家族性糖尿病。
Q J Med. 1974 Apr;43(170):339-57.
5
Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?格列本脲，一种新型磺酰脲类药物：口服降糖药何去何从？
Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001.
6
[Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients].血糖降低类磺酰胺对成年糖尿病患者葡萄糖耐量和胰岛素分泌的长期影响
Verh Dtsch Ges Inn Med. 1973;79:1216-20.
7
[Glibenclamide in type II diabetes as compared with placebo].
Wien Klin Wochenschr. 1983 Mar 18;95(6):200-3.
8
9
Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.磺酰脲类药物与胰岛素：1型（胰岛素依赖型）糖尿病的联合治疗
Diabetologia. 1985 Mar;28(3):182. doi: 10.1007/BF00273870.
10
Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation.
Acta Diabetol Lat. 1972 Nov-Dec;9(6):865-99. doi: 10.1007/BF01564590.
引用本文的文献
1
Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.甲苯磺丁脲不会改变1型（胰岛素依赖型）糖尿病患者的胰岛素需求量。
Diabetologia. 1984 Jul;27(1):8-12. doi: 10.1007/BF00253493.
2
Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.磺酰脲类药物与胰岛素：1型（胰岛素依赖型）糖尿病的联合治疗
Diabetologia. 1985 Mar;28(3):182. doi: 10.1007/BF00273870.
3
The insulin receptor concept and its relation to the treatment of diabetes.胰岛素受体概念及其与糖尿病治疗的关系。
Drugs. 1987 Feb;33(2):156-70. doi: 10.2165/00003495-198733020-00004.
本文引用的文献
1
Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.一种磺脲类药物增加人成纤维细胞胰岛素受体的直接体外效应。
J Clin Invest. 1980 Sep;66(3):608-11. doi: 10.1172/JCI109894.
2
Determination of free and total insulin and C-peptide in insulin-treated diabetics.胰岛素治疗糖尿病患者中游离及总胰岛素和C肽的测定
Diabetes. 1977 Jan;26(1):22-9. doi: 10.2337/diab.26.1.22.
3
C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
Metabolism. 1978 Jan;27(1):35-44. doi: 10.1016/0026-0495(78)90121-x.
4
C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.
Acta Paediatr Scand. 1977 Mar;66(2):177-84. doi: 10.1111/j.1651-2227.1977.tb07830.x.
5
Zotero 插件